Jose Antonio Amat, MD

Frances Rudnick Levin, MD is the Kennedy-Leavy Professor of Psychiatry at Columbia University and the Chief of the Division on Substance Use Disorders at NYSPI/Columbia University. For over twenty years, she served as the Director of the Addiction Psychiatry Fellowship Program at New York-Presbyterian Hospital and for the past sixteen years, she has been the PI of a T32 NIDA funded Substance Abuse Research Fellowship which has been continuously funded since 1994. Dr. Levin graduated from Cornell University Medical College and completed her psychiatric residency at the New York Hospital-Payne Whitney Clinic. Subsequently, she graduated from a 2-year combined clinical and research fellowship at the University of Maryland and the Addiction Research Center, the intramural branch of the National Institute on Drug Abuse (NIDA). Currently, she serves as the Medical Director of the Providers’ Clinical Support System (PCSS), a SAMHSA-supported national training and mentoring initiative focused on addressing the opioid use disorder crisis. Also, she is the Medical Director of a SAMHSA-supported State Targeted Response technical assistance grant (the Opioid Response Network) to address the national opioid epidemic. Dr. Levin, working with other senior faculty, inaugurated the university-wide Center for Healing of Opioid and Other Substance Use Disorders: Enhancing Intervention Development and Implementation (CHOSEN) in 2020 and serves as one of the senior Directors. Moreover, she is the principal investigator of several federal grants, including a K24 Mid-Career Investigator Award as well as a Co-Investigator on numerous other grants. Her current research interests include pharmacologic and psychotherapeutic treatment interventions for opioid, cocaine and marijuana use disorders, and treatment approaches for adults with substance use disorders and attention-deficit hyperactivity disorder along with other psychiatric illnesses. Dr. Levin has over two-hundred and fifty articles and book chapters on a wide range of topics including treatments of substance use disorders, assessment, and treatment of co-occurring psychiatric illnesses and vulnerabilities associated with substance use disorders. She has served on several advisory panels and ad-hoc federal grant review groups and was a member of the NIDA – Initial Review Group: Training and Career Development Subcommittee for eight years and served as a member to the NIDA Interventions to Prevent and Treat Addiction (IPTA). She is currently on the Board of Directors for the American Academy of Addiction Psychiatry (AAAP), the College on Drug Dependence (CPDD), and the American Society of ADHD and Related Disorders (APSARD). She is an editorial board member of three journals, past President of the American Academy of Addiction Psychiatry, and past Chair of the APA Council on Addiction Psychiatry.

Dr. Mishkin is a native New Yorker. She completed Medical School and a Public Health Master's degree in New Orleans at Tulane University, and moved back to New York to continue specialization training in psychiatry (at St. Luke's-Roosevelt) and then in psychosomatic medicine (at Montefiore). She then completed her MBEat the Montefiore-Einstein Center for Bioethics.She is the psychiatric liaison to the Blood and Marrow Transplantation Program at New York Presbyterian Hospital. Her interests include psychiatric care of patients with life-threatening illness, cancer, sickle cell disease, infertility and subfertility, medical post-traumatic stress, clinician mental health, surrogate decision-making, public health, access to care and equity.

Dr. Fedoronko is an Assistant Clinical Professor of Psychiatry in the Consultation-Liaison and Behavioral Medicine division. He received an undergraduate degree in chemistry from Wayne State University before studying medicine at the University of Michigan Medical School. He completed residency in psychiatry at New York-Presbyterian Hospital/Weill Cornell Medical Center. He then came to Columbia to complete a fellowship in consultation-liaison psychiatry. He has remained on faculty since that time. He currently serves as liaison to the lung transplant, heart transplant, and heart failure programs at NewYork-Presbyterian Hospital. He additionally serves as a consultant to the general hospital. His interests include the management of mood and anxiety disorders in patients with severe medical illness and the influence of personality style on coping mechanisms and medical outcomes. He is active in teaching as he directs the consultation-liaison component of the third year medical student clerkship in psychiatry. Dr. Fedoronko is also active in clinical supervising and lecturing to psychiatry residents and fellows. Past honors include the William Webb Fellowship from the Academy of Psychosomatic Medicine, the outstanding graduate in consultation-liaison psychiatry from NewYork-Presbyterian Hospital/Weill Cornell Medical Center, the Raymond Waggoner Award from the University of Michigan Medical School, and election to Alpha Omega Alpha Honor Medical Society.